Reported positive update from Phase 2 CRDF-004 trial in first-line RAS-mutated mCRC, with the 30 mg onvansertib + FOLFIRI/bev arm demonstrating:• ...
Company entering 2026 with the potential to deliver multiple value-driving milestones, including data readouts from ARV-102, ARV-806, and ARV-393, with cash runway into second half of 2028 - ...
The Government of Panama has taken control of the Balboa and Cristóbal container terminals after the Supreme Court annulled ...
It is an honor and a privilege to lead such a talented and committed team as Arvinas enters a period where we anticipate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results